Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTissue DonorsHistocompatibilityHematopoietic Stem Cell TransplantationHistocompatibility TestingGraft SurvivalLiving DonorsKidney TransplantationTransplantation ConditioningBone and BonesWhole-Body IrradiationImmunosuppressive AgentsLeukemiaGraft RejectionHematologic NeoplasmsTissue and Organ ProcurementTreatment OutcomeTransplantation ChimeraTransplantation, AutologousAnemia, AplasticHLA AntigensUnrelated DonorsCadaverCytomegalovirus InfectionsDirected Tissue DonationAntilymphocyte SerumRetrospective StudiesSevere Combined ImmunodeficiencyLymphocyte DepletionTime FactorsHematopoietic Stem CellsLeukemia, Myeloid, AcuteRecurrenceImmunosuppressionImmunocompromised HostHaploidyBone RemodelingBone Marrow DiseasesTransplantsCyclosporineT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationOpportunistic InfectionsSurvival RateWaiting ListsBone Marrow PurgingSurvival AnalysisBone Marrow NeoplasmsLymphocyte TransfusionHaplotypesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePeripheral Blood Stem Cell TransplantationAcute DiseaseMice, Inbred C57BLHematopoiesisMycosesCytomegalovirusBlood DonorsCyclophosphamideBone DensityRadiation ChimeraGraft vs Leukemia EffectBusulfanFatal OutcomeTransplantation, IsogeneicFetal TherapiesTransplantationHeart TransplantationAntigens, CD34GanciclovirHematologic DiseasesBone ResorptionStem Cell TransplantationCord Blood Stem Cell TransplantationPneumonia, ViralColony-Forming Units AssayNuclear FamilyDisease-Free SurvivalRisk FactorsSiblingsFollow-Up StudiesPostoperative ComplicationsRemission InductionAspergillosisGraft vs Host ReactionCombined Modality TherapyBlood Group IncompatibilityMyelodysplastic SyndromesCell DifferentiationLeukemia, MyeloidLung TransplantationPolymerase Chain ReactionHepatic Veno-Occlusive DiseaseGranulocyte Colony-Stimulating FactorCystitis